Panacea Index Logo

Command Palette

Search for a command to run...

Interval Walking Improves Glycemic Control and Body Composition After Cancer Treatment: A Randomized Controlled Trial.

The Journal of clinical endocrinology and metabolism
January 1, 1970
Jesper F Christensen et al. (17 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

To examine the effects of home-based interval walking on aerobic and metabolic fitness and quality of life in patients with colorectal cancer.

Results Summary

Interval walking significantly improved postprandial glycemic control, counteracted fat gain, and improved the Matsuda index, but had no effect on VO2peak.

Population

Sedentary patients with stage I to III colorectal cancer who had completed primary treatment.

Effective Dosage

150 minutes per week of home-based interval walking.

Duration

12 weeks.

Interactions

None mentioned.

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Home-based interval walking
no change
maximum oxygen uptake (VO2peak)
patients with stage I to III colorectal cancer who had completed primary treatment
mean between-group difference: -0.32 mL O2 · kg-1 · min-1 (-2.09 to 1.45)
had no effect on
#1
Home-based interval walking
increase
postprandial glycemic control
patients with stage I to III colorectal cancer who had completed primary treatment
-
significantly improved
#2
Home-based interval walking
decrease
glucose OGTT area under the curve
patients with stage I to III colorectal cancer who had completed primary treatment
-126 mM · min (-219 to -33)
lower
#3
Home-based interval walking
decrease
2-hour glucose concentration
patients with stage I to III colorectal cancer who had completed primary treatment
-1.1 mM (-2.2 to 0.0)
lower
#4
Home-based interval walking
increase
Matsuda index
patients with stage I to III colorectal cancer who had completed primary treatment
1.94 (0.34; 3.54)
improved
#5
Home-based interval walking
decrease
fat mass
patients with stage I to III colorectal cancer who had completed primary treatment
-1.47 kg (-2.74 to -0.19)
counteracted an increase in
#6
Abstract

CONTEXT: Patients with colorectal cancer have increased risk of metabolic diseases including diabetes. Exercise training may counteract metabolic dysregulation, but the impact of exercise training on glycemic control, including postprandial glycemia, has never been explored in patients with colorectal cancer. OBJECTIVE: To examine the effects of home-based interval walking on aerobic and metabolic fitness and quality of life in patients with colorectal cancer. DESIGN: Randomized controlled trial. SETTING: Clinical research center. PARTICIPANTS: Thirty-nine sedentary (<150 minutes moderate-intensity exercise per week) patients with stage I to III colorectal cancer who had completed primary treatment. INTERVENTION: Home-based interval walking 150 min/wk or usual care for 12 weeks. MAIN OUTCOME MEASURES: Changes from baseline to week 12 in maximum oxygen uptake (VO2peak) by cardiopulmonary exercise test, glycemic control by oral glucose tolerance test (OGTT), body composition by dual-energy x-ray absorptiometry scan, blood biochemistry, and quality of life. RESULTS: Compared with control, interval walking had no effect on VO2peak [mean between-group difference: -0.32 mL O2 · kg-1 · min-1 (-2.09 to 1.45); P = 0.721] but significantly improved postprandial glycemic control with lower glucose OGTT area under the curve [-126 mM · min (-219 to -33); P = 0.009], 2-hour glucose concentration [-1.1 mM (-2.2 to 0.0); P = 0.056], and improved Matsuda index [1.94 (0.34; 3.54); P = 0.01]. Also, interval walking counteracted an increase in fat mass in the control group [-1.47 kg (-2.74 to -0.19); P = 0.025]. CONCLUSION: A home-based interval-walking program led to substantial improvements in postprandial glycemic control and counteracted fat gain in posttreatment patients with colorectal cancer, possibly providing an effective strategy for prevention of secondary metabolic diseases.

Medical Subject Headings (MeSH)
BiomarkersBlood GlucoseCase-Control StudiesExerciseFemaleFollow-Up StudiesGlucose Tolerance TestHumansHyperglycemiaHypoglycemiaMaleMiddle AgedNeoplasmsOxygen ConsumptionPrognosisProspective StudiesQuality of LifeWalking
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality90/10
Citation Metrics
Total Citations14
Citations/Year2.3
Relative Citation Ratio0.76
NIH Percentile40.2%
Research Impact Scores
APT Score0.75
Weight Score1.83
Normalized Score0.72
Related Supplements
Interval Walking Improves Glycemic Control and Body Composit... | Panacea Index